Brookstone Capital Management Moderna, Inc. Transaction History

Brookstone Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$126.46 - $235.05 $195,380 - $363,152	-1,545 Closed	0 $0
Q4 2021 Jan 11, 2022	SELL	$225.82 - $368.51 $1.16 Million - $1.9 Million	-5,145 Reduced 76.91%	1,545 $330,000
Q3 2021 Nov 03, 2021	BUY	$221.9 - $484.47 $1.28 Million - $2.8 Million	5,786 Added 640.04%	6,690 $2.15 Million
Q2 2021 Jul 14, 2021	BUY	$129.91 - $234.98 $117,438 - $212,421	904 New	904 $213,000
Q3 2020 Oct 13, 2020	SELL	$54.34 - $94.85 $312,781 - $545,956	-5,756 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$29.67 - $80.0 $170,780 - $460,480	5,756 New	5,756 $370,000

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

Stay updated on Brookstone Capital Management with notifications on news.